ITT1929
ITT1929
- Catalog: ITT1929
- Gene/Protein: SLC2A3
- Product Description: Immunotag™ Glut3 Polyclonal Antibody
385.0000
Price in reward points: 385
Your shopping cart is empty!
Antibody Specification | |
Datasheet | |
Target Protein | Glut3 |
Clonality | Polyclonal |
Storage/Stability | -20°C/1 year |
Application | WB,IHC-p,ELISA |
Recommended Dilution | Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/10000. Not yet tested in other applications. |
Concentration | 1 mg/ml |
Reactive Species | Human |
Host Species | Rabbit |
Immunogen | The antiserum was produced against synthesized peptide derived from human GLUT3. AA range:447-496 |
Specificity | Glut3 Polyclonal Antibody detects endogenous levels of Glut3 protein. |
Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen |
Form | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
Gene Name | SLC2A3 |
Accession No. | P11169 P32037 |
Alternate Names | SLC2A3; GLUT3; Solute carrier family 2; facilitated glucose transporter member 3; Glucose transporter type 3, brain; GLUT-3 |
Description | function:Facilitative glucose transporter. Probably a neuronal glucose transporter.,similarity:Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily.,tissue specificity:Highly expressed in brain. Expressed in many tissues., |
Protein Expression | Articular cartilage,Duodenum,Fetal skeletal muscle,Spleen, |
Subcellular Localization | plasma membrane,integral component of plasma membrane,integral component of membrane,extracellular exosome, |
Protein Function | function:Facilitative glucose transporter. Probably a neuronal glucose transporter.,similarity:Belongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily.,tissue specificity:Highly expressed in brain. Expressed in many tissues., |
Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |